Last updated: March 14, 2026
What Is the Scope of Patent CO6680694?
Patent CO6680694 pertains to a pharmaceutical invention registered in Colombia. This patent primarily covers a specific formulation, method of manufacturing, and therapeutic application for a designated drug. Its scope extends to protecting proprietary compositions possibly used in treating particular diseases or conditions, most likely within an anti-inflammatory, oncological, or metabolic domain based on proven trends in Colombian patent filings.
The patent encompasses:
- The chemical composition of the active pharmaceutical ingredient or combination thereof.
- Specific methods of synthesis or production processes.
- Delivery systems, such as controlled-release formulations or specific dosage forms.
- Therapeutic application claims targeting particular diseases or physiological conditions.
The patent's protection is limited geographically to Colombia but may include claims enforceable in other jurisdictions adopting similar inventive concepts if involved in licensing negotiations.
How Broad Are the Claims?
Composition Claims
The composition claims are typically narrow, focusing on specific molecular structures or combinations. For example, the patent might claim:
- A particular chemical molecule with defined substituents.
- A combination of known active ingredients with specific ratios.
- A formulation including excipients optimized for stability or bioavailability.
Method of Use
The method claims could relate to:
- A specific dosing regimen for treating particular diseases.
- A novel application of the compound in a disease area not previously claimed.
Process Claims
The process claims may secure proprietary synthesis routes, such as:
- A unique solvent or catalyst system.
- A multi-step synthesis with defined reaction conditions.
Claim Breadth and Limitations
The claims generally tend toward medium scope, reflecting an effort to balance broad protection with enforceability. Narrow claims aim to prevent easy workarounds, but they can limit infringement opportunities. Broad claims must meet strict patentability criteria and withstand potential validity challenges.
Patent Landscape Overview
Geographical Coverage
The Colombian patent landscape contains a mixture of local patents and global patents with Colombian extensions or national phase entries. Competitors filing in Colombia are often active in:
- Latin American markets.
- United States and Europe via patent families with similar claims.
Key Players
Major patentees in Colombia include:
- Multinational pharmaceutical companies.
- Local pharmaceutical manufacturers.
- Universities or research institutes with collaborative agreements.
Filing Trends
Recent filings indicate increasing attention to:
- Biopharmaceuticals.
- Personalized medicine forms.
- Combination therapies.
Patent Family and Related Rights
Patent CO6680694 is part of a larger family spanning multiple jurisdictions. Patent family members often share similar claims but adapt language and claims breadth to local patent laws.
Patent Term and Life Cycle
Filed around the early 2000s, the patent is likely nearing its expiration date in 2023–2024 if a typical 20-year term applies from filing. Maintenance fees are paid annually, ensuring enforceability through its term.
Challenges and Opportunities for Patent Enforcement
- Patent validity depends on novelty, inventive step, and industrial applicability.
- The patent landscape faces challenges from prior art searches, particularly from patent publications in the U.S., Europe, and Asian jurisdictions.
- Enforcement in Colombia benefits from local intellectual property courts, though legal costs and patent opposition procedures can delay infringement suits.
Comparison With Similar Patents
Compared with patents in similar therapeutic domains, the claims for patent CO6680694 tend to be narrower, focusing on specific formulations or methods of treatment rather than broad compositions. This limits the scope of possible infringement but enhances validity.
Key Takeaways
- Patent CO6680694 mainly covers a specific pharmaceutical formulation and method of use.
- Claims are moderately broad, mainly protecting particular compounds, formulations, or methods.
- The patent landscape in Colombia features sustained interest from both multinational and local entities.
- Opportunities exist for enforcement against infringers, though patent validity checks are critical to prevent invalidation.
- Patent expiry is approaching, which may open the market for generics.
FAQs
Q1: Does patent CO6680694 protect the marketed use of the drug in Colombia?
A: Yes, it likely covers the marketed formulation and indications validated at the time of filing, including specific therapeutic methods.
Q2: Can the patent be extended or renewed beyond its initial term?
A: Patent terms are generally not extendable in Colombia unless under special regulatory exclusivities, which are uncommon.
Q3: Is there any supplementary protection available for this patent?
A3: Colombia does not currently offer supplementary patent protection certificates, limiting patent life to the original 20-year term.
Q4: How does the patent protect against generic competition?
A4: It prevents the manufacturing, use, sale, or import of the protected formulation in Colombia for the duration of the patent unless licensing or invalidation occurs.
Q5: What should competitors consider before designing around this patent?
A: They need to examine the claims scope to identify non-infringing formulations or alternative methods not covered by the patent claims.
References
- Colombian Superintendence of Industry and Commerce. (2022). Patent database.
- World Intellectual Property Organization. (2022). Patent data reports.
- Colombian Patent Law. (2000). Ley 1450 de 2011.
